The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses) 41,850.00 52,880.00 14 Dividends payable 23,200.00 19,880.00 15 Common stock, $2 par 150,000.00 100,000.00 16 Paid-in capital: Excess of issue price over par—common stock 417,500.00 280,000.00 17 Retained earnings 1,307,110.00 1,199,460.00 18 Total liabilities and stockholders’ equity $2,363,960.00 $2,057,080.00 The income statement for the year ended December 31, 20Y3, is as follows: 1 Sales $5,378,129.00 2 Cost of goods sold 3,306,510.00 3 Gross profit $2,071,619.00 4 Operating expenses: 5 Depreciation expense $18,570.00 6 Other operating expenses 1,755,879.00 7 Total operating expenses 1,774,449.00 8 Operating income $297,170.00 9 Other income: 10 Gain on sale of investments 40,390.00 11 Income before income tax $337,560.00 12 Income tax expense 133,650.00 13 Net income $203,910.00 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: a. The investments were sold for $280,680 cash. b. Equipment and land were acquired for cash. c. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $96,260 debit to Retained Earnings for cash dividends declared.
Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities. Be sure to complete the heading of the statement. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Enter amounts that represent cash outflows as negative numbers using a minus sign.
Expert Answer
LIVERS INC. | |||
Statement of Cash Flows | |||
For the Year Ended December 31, 20Y3 | |||
Cash flows from operating activities: | |||
Cash received from customers1 | $5,357,989 | ||
Deduct: Cash payments for merchandise2 | $3,311,420 | ||
Cash payments for operating expenses3 | 1,766,909 | ||
Cash payments for income taxes | 133,650 | 5,211,979 | |
Net cash flow from operating activities | $146,010 | ||
Cash flows from investing activities: | |||
Cash received from sale of investments | $280,680 | ||
Less: Cash paid for purchase of land | ($328,170) | ||
Cash paid for purchase of equipment | -153,770 | -481,940 | |
Net cash flow used for investing activities | -201,260 | ||
Cash flows from financing activities: | |||
Cash received from sale of common stock | $187,500 | ||
Less cash paid for dividends* | 92,940 | ||
Net cash flow from financing activities | 94,560 | ||
Increase in cash | $39,310 | ||
Cash at the beginning of the year | 586,340 | ||
Cash at the end of the year | $625,650 | ||
*96260+19880-23200 = 92940 |
1 | Sales | $5,378,129 |
Deduct increase in accounts receivable | 20,140 | |
Cash received from customers | $5,357,989 | |
2 | Cost of merchandise sold | $3,306,510 |
Add increase in inventories | 24,350 | |
$3,330,860 | ||
Deduct increase in accounts payable | 19,440 | |
Cash payments for merchandise | $3,311,420 | |
3 | Operating expenses other than depreciation | $1,755,879 |
Add decrease in accrued expenses payable | 11,030 | |
Cash payments for operating expenses | $1,766,909 |